As European markets experience a rally, buoyed by geopolitical developments and investor optimism, the region's growth companies are drawing attention for their potential amid shifting economic forecasts. In this context, stocks with high insider ownership can be particularly appealing as they often reflect management's confidence in the company's long-term prospects and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| MilDef Group (OM:MILDEF) | 13.7% | 34.7% |
| KebNi (OM:KEBNI B) | 35% | 72.8% |
| Induct (OB:INDCT) | 10.5% | 98.6% |
| Hacksaw (OM:HACK) | 13.2% | 25.3% |
| Elliptic Laboratories (OB:ELABS) | 19.8% | 124.9% |
| CTT Systems (OM:CTT) | 17.4% | 42.7% |
| Clavister Holding AB (publ.) (OM:CLAV) | 18% | 116.2% |
| Circus (XTRA:CA1) | 21.9% | 88.1% |
| Bonesupport Holding (OM:BONEX) | 10.2% | 33.7% |
| Bergen Carbon Solutions (OB:BCS) | 10.2% | 55.5% |
Here's a peek at a few of the choices from the screener.
Ercros (BME:ECR)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Ercros, S.A. operates in the chemical and pharmaceutical sectors, producing and distributing its products both in Spain and globally, with a market cap of €311.80 million.
Operations: Ercros generates revenue from three main segments: Pharmaceuticals (€60.38 million), Chlorine Derivatives (€367.14 million), and Intermediate Chemicals (€175.84 million).
Insider Ownership: 14.6%
Ercros, S.A. faces challenges with a net loss of €53.59 million for 2025 and high debt levels, but it is expected to achieve profitability within three years, outpacing average market growth. Despite slower revenue growth at 8.4% annually compared to the ideal threshold, it surpasses the Spanish market's rate of 6.2%. The company trades at good value relative to peers and industry standards, although insider ownership remains stable amid recent M&A disruptions.
- Click to explore a detailed breakdown of our findings in Ercros' earnings growth report.
- Upon reviewing our latest valuation report, Ercros' share price might be too pessimistic.
Lime Technologies (OM:LIME)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lime Technologies AB (publ) provides software as a service (SaaS) based customer relationship management (CRM) solutions in the Nordic region, with a market cap of SEK2.73 billion.
Operations: The company generates revenue from selling and implementing CRM software systems, amounting to SEK747.55 million.
Insider Ownership: 10.7%
Lime Technologies shows robust insider confidence with substantial insider buying over the past three months. The company’s earnings grew by 24.9% last year and are forecast to grow at 14.07% annually, outpacing the Swedish market's growth rate of 9.8%. Trading at 40.7% below estimated fair value, Lime offers potential upside despite slower revenue growth of 8.3%, which still exceeds the Swedish market average of 0.9%.
- Unlock comprehensive insights into our analysis of Lime Technologies stock in this growth report.
- According our valuation report, there's an indication that Lime Technologies' share price might be on the expensive side.
Leonteq (SWX:LEON)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Leonteq AG is a company that offers derivative investment products and services across Switzerland, Europe, Asia, and internationally, with a market cap of CHF278.31 million.
Operations: Leonteq's revenue from its brokerage segment amounts to CHF170.35 million.
Insider Ownership: 12.3%
Leonteq demonstrates significant insider ownership, with recent transactions indicating a shift in shareholder structure as a group acquires a 22.7% stake from Raiffeisen. Despite reporting a CHF 33.7 million loss for 2025 and halting dividends, Leonteq's revenue is expected to grow at 13.3% annually, surpassing the Swiss market average. The company anticipates profitability within three years; however, its volatile share price and debt coverage issues present challenges amidst strategic board changes and expanding market initiatives.
- Delve into the full analysis future growth report here for a deeper understanding of Leonteq.
- Our valuation report unveils the possibility Leonteq's shares may be trading at a discount.
Summing It All Up
- Reveal the 216 hidden gems among our Fast Growing European Companies With High Insider Ownership screener with a single click here.
- Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Ercros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About BME:ECR
Ercros
Manufactures and sells chemical and pharmaceutical products in Spain and internationally.
Reasonable growth potential and fair value.
Similar Companies
Market Insights
Weekly Picks

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

The $135 Billion Bet That Should Make Every Shareholder Nervous
Orbit + Aero + Defense

A case for Steppe Gold, bear case CAD $4, base case CAD $15, bull case CAD $25
Recently Updated Narratives
Sern Kou Resource Stands to Benefit from Supply Chain Tightness and Pricing Power
Circus SE's AI-driven food systems will revolutionize global food service

Peru/Canada 15 Baggers Near-Producer Silver Play
Popular Narratives

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.
NVIDIA will see a profit margin surge of 55% in the next 5 years

